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Recently, the world’s first transgenic dogs were produced 
b y  s o m a t i c  c e l l  n u c l e a r  t r a n s f e r .  H o w e v e r ,  c e l l u l a r  
senescence is a major limiting factor for producing more 
advanced transgenic dogs. To overcome this obstacle, we 
rejuvenated transgenic cells using a re-cloning technique. 
Fibroblasts  from  post-mortem  red  fluorescent  protein 
(RFP) dog were reconstructed with in vivo matured oocytes 
and transferred into 10 surrogate dogs. One puppy was 
produced and confirmed as a re-cloned dog. Although the 
puppy was lost during birth, we successfully established a 
rejuvenated fibroblast cell line from this animal. The cell 
l i n e  w a s  f o u n d  t o  s t a b l y  e x p r e s s  R F P  a n d  i s  r e a d y  f o r  
additional genetic modification.
Keywords: re-cloned dog, RFP dog, serial cloning, somatic cell 
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Somatic cell nuclear transfer (SCNT) is currently the only 
technique suitable for producing transgenic dogs because 
the use of technologies appropriate for other species, such 
as germline-transmissible embryonic stem cells and in 
vitro embryo culture, have not yet been established in dogs. 
However, SCNT is associated with a number of 
limitations. To establish transgenic donor cells for SCNT, 
transfection and selection procedures must be performed 
[14]. During this process, the donor cells can easily 
become senescent and the number of transgenic cells that 
can be used for SCNT are limited [4]. In particular, gene 
targeting by homologous recombination or multiple 
transfections that require two or more rounds of selection 
[3] is extremely hard to perform with primary cultured 
cells that are necessary for SCNT.
In 1998, Cibelli et al. [3] suggested an alternative strategy 
to overcome these obstacles by using a serial cloning 
technique. In their study, they produced cloned fetuses 
derived from senescent bovine fibroblasts and then 
successfully isolated non-senescent fibroblasts from the 
fetuses. It had already been proven that non-senescent cells 
from cloned animals can be used to produce re-cloned 
offspring in several species including cattle [7], pigs [2], 
and cats [1]. Thus, the life-span of the cells can be 
theoretically elongated infinitely using this serial cloning 
technique. Furthermore, complex genetic modification 
could be performed as much as desired if the transgenes 
were successfully transferred to the re-cloned transgenic 
animals. Currently, the potential for serial cloning in dogs 
and the extent of transmission of the transgene from 
transgenic dogs to re-cloned dogs is unclear. Therefore, the 
present study was performed to produce re-cloned 
offspring from our red fluorescent protein (RFP) 
transgenic dog and to analyze expression of the RFP gene 
in the re-cloned dog. A re-cloned transgenic cell line for 
further serial cloning was also established.
In our previous report [6], four female and two male RFP 
dogs were successfully produced by SCNT. However, one 
of the male dogs was died due to chronic bronchopneumonia 
at 11 weeks after birth. To re-clone the deceased RFP dog 
(R6), we harvested fibroblasts 2 h after the death of the 
puppy and established a cloned transgenic cell line. The 
same SCNT and embryo transfer procedures described in 
our previous reports [6,8-10] were used for re-cloning in 
the present study. In total, 174 re-cloned embryos 
reconstructed with fibroblasts derived from R6 were 
transferred into the oviducts of 10 estrous-synchronized 
surrogate dogs. Two surrogates became pregnant but one 
experienced an abortion around 1 month of gestation. On 
Day 62 of gestation, the pregnant surrogate delivered one 
male puppy (rcR6). Unfortunately, the puppy was lost 
during birth.
To validate that rcR6 was a clone of R6, microsatellite and 
mitochondrial DNA sequencing analyses were performed 
[11]. As shown in Table 1, rcR6 was genetically identical to 
the cell donor, R6, while the mitochondrial DNA sequence 
was identical to the oocyte donor but different from that of 406    So Gun Hong et al.
Fig. 1. Expression of red fluorescent protein (RFP) in the organs 
of the re-cloned dog. (A and a) spleen, (B and b) kidney, (C and
c) trachea and lung, (D and d) stomach and intestine, (E and e) 
liver, (F and f) heart. (A∼F) Visible light images. (a∼f) 
Fluorescence images.
Table 1. Microsatellite analysis of the re-cloned dog
Marker*
PEZ 001 PEZ 005 PEZ 006 PEZ 008 PEZ 012 PEZ 020 FH 2010 FH 2079
R6 114/122 101/105 199/199 223/231 265/277 175/179 228/232 273/273
rcR6 114/122 101/105 199/199 223/231 265/277 175/179 228/232 273/273
Oocyte donor 114/126 97/109 175/183 231/235 269/277 175/183 232/236 269/273
Surrogate 118/118 101/101 175/183 223/243 261/293 175/175 232/236 269/269
*The isolated genomic DNA samples were used for microsatellite assay with eight specific markers originally derived from dogs.
R6: red fluorescent protein transgenic dog, rcR6: re-cloned dog derived from R6.
Table 2. Sequence alignments within 661 bases of the hypervariable mitochondrial DNA region
Sample
Nucleotide position
1
5
4
3
5
1
5
4
8
3
1
5
5
0
8
1
5
5
2
6
1
5
5
9
5
1
5
6
1
1
1
5
6
1
2
1
5
6
2
7
1
5
6
3
2
1
5
4
3
9
1
5
6
4
3
1
5
6
5
0
1
5
6
5
2
1
5
7
1
0
1
5
8
0
0
1
5
8
1
4
1
5
8
1
5
1
5
9
1
2
1
5
9
5
5
1
6
0
0
3
1
6
0
8
3
Reference* G CCCCTTACTATGCTCTCCAA
R 6 G CCCCTTACTATGCTTTCCAA
rcR6 G T C C C T T G C A A T G C T T T T C A A
Oocyte donor G T C C C T T G C A A T G C T T T T C A A
S u r r o g a t e A CCTTTCATGGTACCTCTTGG
*The nucleotide positions are numbered according to those of GenBank accession no U96639 v.2; 661 bases (from 5431 to 16091) were 
examined.
the R6 and surrogate dog (Table 2). These data revealed 
that rcR6 was a clone of R6. The expression of RFP in rcR6 
was also evaluated. Similar to the RFP expression in R6 
[6], rcR6 also expressed RFP in all of the examined organs 
(Fig. 1). Therefore, we concluded that the phenotypes of 
transgenic dogs can be inherited by the re-cloned offspring. 
To establish a re-cloned transgenic cell line, fibroblasts 
were harvested from rcR6 then cultured in vitro. The 
re-cloned fibroblasts grew robustly, were morphologically 
normal (Fig. 2A), and stably expressed RFP (Figs. 2B and 
C).
In the present study, we failed to obtain a viable re-cloned 
dog although the puppy almost developed to full-term and 
died during the delivery process. Additionally, the overall 
re-cloning efficiency in this report was inferior to that of a 
previous report on cloning R6 [6]. Thus, the canine 
re-cloning procedure developed in the present study still 
requires some improvement. Several previous reports have 
shown that cloning efficiency is decreased by re-cloning 
[5,13] especially if adult cells isolated from cloned animals 
are used as donor cells for SCNT [14] as was the case in the 
present study. However, this phenomenon can be 
overcome in mice by using histone deacetylase inhibitors 
such as trichostatin A to epigenetically reprogram donor 
cells, or by using stem cells derived from cloned animals as 
donor cells for SCNT [12]. We also found similar Re-cloned transgenic dog    407
Fig. 2. Transgenic cell line established from the re-cloned dog. 
(A) Visible light image. (B) Fluorescence image. Scale bar = 100
µm. (C) PCR analysis of the RFP gene. M: marker, C: wild-type, 
R6: RFP transgenic dog, rcR6: re-cloned dog derived from R6.
tendencies for both of these strategies during canine 
re-cloning (data not shown) and further studies are being 
conducted to confirm our observation.
In conclusion, we demonstrated the possibility of 
producing a re-cloned transgenic dog. The RFP transgene 
was inherited by the offspring and was highly expressed 
after re-cloning. A re-cloned transgenic cell line suitable 
for further serial cloning was also successfully established. 
This technology will be useful for producing dogs with 
multiple modified genes or gene targeting in canines.
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